Nephrosclerosis: Clinical Trials

2 trials for Nephrosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Nephrosclerosis: new trials by email Literature Review of Nephrosclerosis trials Research Report on Nephrosclerosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
TRK-100STP high dose, TRK-100STP low dose, Placebo - Chronic Renal Failure, Glomerular Disease
Phase 2 / Phase 3CompletedToray Industries, Inc8922010-03-012015-02-04
TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Beraprost, Placebo - Renal Insufficiency, Chronic
Phase 2CompletedToray Industries, Inc1132005-10-012015-06-29

Narrower conditions

Kidney Failure, Chronic (2)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Renal Insufficiency (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Renal Insufficiency, Chronic (1)

Interventions

beraprost (1)

Sponsors

Toray Industries, Inc (2)

Countries

China (1)  ·  Hong Kong (1)  ·  Japan (1)  ·  Malaysia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Thailand (1)

Results publications

PMID 25233856, PMID 26475266, PMID 35224730